BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18216357)

  • 1. Chimerism and tolerance in a recipient of a deceased-donor liver transplant.
    Alexander SI; Smith N; Hu M; Verran D; Shun A; Dorney S; Smith A; Webster B; Shaw PJ; Lammi A; Stormon MO
    N Engl J Med; 2008 Jan; 358(4):369-74. PubMed ID: 18216357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
    Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
    Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and chimerism after renal and hematopoietic-cell transplantation.
    Scandling JD; Busque S; Dejbakhsh-Jones S; Benike C; Millan MT; Shizuru JA; Hoppe RT; Lowsky R; Engleman EG; Strober S
    N Engl J Med; 2008 Jan; 358(4):362-8. PubMed ID: 18216356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression.
    Pons JA; Yélamos J; Ramírez P; Oliver-Bonet M; Sánchez A; Rodríguez-Gago M; Navarro J; Bermejo J; Robles R; Parrilla P
    Transplantation; 2003 Apr; 75(7):1045-7. PubMed ID: 12698096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism.
    Pageaux GP; Perrigault PF; Fabre JM; Portales P; Souche B; Dereure O; Eliaou JF; Larrey D; Domergue J; Michel H
    Clin Transplant; 1995 Feb; 9(1):65-9. PubMed ID: 7742585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
    Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
    Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
    Wu BY; Guo KY; Song CY; Yang ; Li D
    Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplant with clinical tolerance, laboratory evidence of chimerism, and spontaneous clearance of HBV.
    Stone JJ; Chang SH; Kimball PM; Stravitz RT; Fisher RA
    Liver Transpl; 2004 Nov; 10(11):1432-5. PubMed ID: 15497148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance in mixed chimerism - a role for regulatory cells?
    Kurtz J; Wekerle T; Sykes M
    Trends Immunol; 2004 Oct; 25(10):518-23. PubMed ID: 15364053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimerism and tolerance in a recipient of a deceased-donor liver transplant.
    Lund T; Tolar J
    N Engl J Med; 2008 May; 358(19):2075; author reply 2075. PubMed ID: 18463388
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Abo T; Hatakeyama K
    Hepatogastroenterology; 2003; 50(54):2161-5. PubMed ID: 14696487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
    Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
    Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor cell engraftment in recipient lymphoid tissues after rat limb allograft.
    Muramatsu K; Kurokawa Y; Ihara K; You-Xin S; Kawai S
    J Surg Res; 2005 Mar; 124(1):38-44. PubMed ID: 15734477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of microchimerism in pediatric patients after living-related liver transplantation.
    Ueda M; Hundrieser J; Hisanaga M; Tanaka K; Wonigeit K; Pichlmayr R; Schlitt HJ; Yamaoka Y
    Clin Transplant; 1997 Jun; 11(3):193-200. PubMed ID: 9193841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.